Skip to main content
. 2023 Feb 27;13:3321. doi: 10.1038/s41598-023-30500-7

Table 2.

Changes from baseline measurements in ocular parameters for the two groups.

3 Months (n = 43) 6 Months (n = 43) 9 Months (n = 35) 12 Months (n = 35)
PBM group Control group P PBM group Control group P PBM group Control group P PBM group Control group P
Changes in AL (mm) − 0.09 ± 0.07 0.14 ± 0.06 0.001 − 0.07 ± 0.09 0.23 ± 0.11 0.001 − 0.05 ± 0.06 0.36 ± 0.15 0.007 − 0.02 ± 0.11 0.48 ± 0.16 0.000
Changes in CCP (D) − 0.06 ± 0.30 − 0.01 ± 0.27 0.608 − 0.01 ± 0.34 0.00 ± 0.13 0.147 − 0.02 ± 0.29 − 0.13 ± 0.28 0.457 0.16 ± 0.29 0.16 ± 0.36 0.980
Changes in ACD (mm) 0.24 ± 0.28 0.32 ± 0.30 0.396 0.02 ± 0.12 − 0.01 ± 0.07 0.498 0.05 ± 0.11 − 0.01 ± 0.24 0.071 0.04 ± 0.12 − 0.03 ± 0.16 0.170
Changes in SFChT (µm) 17.44 ± 42.37 11.09 ± 31.07 0.715 29.65 ± 50.34 20.60 ± 24.14 0.601 33.2 ± 54.59 − 5.5 ± 25.25 0.210 20.89 ± 39.48 11.14 ± 28.95 0.441
Changes in Cycloplegic SER (D) + 0.28 ± 0.26 − 0.97 ± 0.25 0.000

AL axial length, CCP central cornea power, ACD anterior chamber depth, SFChT subfoveal choroidal thickness, PBM group photomodulation group, Control group single-vision spectacles group, SER cycloplegic spherical equivalent refraction, D dioptre.